u/diego_szabo
Contributes reviews on supplier material. Based in Brno.
member · joined 12 Mar 2025
comment on [Discussion] small community, high signal, let us keep it that way in c/survodutide · 1 points · 9 days ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Discussion] glucagon is doing more work than we give it credit for in c/survodutide · 22 points · 1 months ago
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
comment on [PeptideMeter] ERP tirz 15mg — 98.4% and a very clean trace in c/labresults · 12 points · 1 months ago
comment on [Lab] four vendors, same compound, same week, one test each in c/labresults · 13 points · 1 months ago
Strongly agree. Below-spec results matter as much as good ones.
comment on [Janoshik] FGP cagrilintide — first independent number i have seen for it in c/labresults · 119 points · 1 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on three years of regain threads, summarised so you do not have to read them in c/tapering · 3 points · 3 months ago
the people who came off and restarted without shame
comment on interval stretching — my 5-week log, condensed into one table in c/tapering · 26 points · 4 months ago
Maintenance for 10 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on interval stretching — my 5-week log, condensed into one table in c/tapering · 44 points · 4 months ago
You have restated the marketing copy. What is the actual substance here.
comment on interval stretching — my 5-week log, condensed into one table in c/tapering · 78 points · 4 months ago
This is an urgent-care question wearing a forum question's clothes.
Adding to this: discontinuation is doing more work than the comment implies.
comment on Germany: discontinuation, and what it actually costs here in c/tapering · 15 points · 4 months ago
Mechanistically the bit that matters is regain. It explains most of the early profile and a decent chunk of the outcome.
comment on [Results] 42 weeks, 16kg, and below spec was the hard part in c/labresults · 31 points · 5 months ago
Which VendorInvestigate service and what method did they use?
Disagree on that part. 97.4% and 98.3% on the same vial is normal.
comment on [Results] 42 weeks, 16kg, and below spec was the hard part in c/labresults · 17 points · 5 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on [Results] 42 weeks, 16kg, and below spec was the hard part in c/labresults · 42 points · 5 months ago
ERP claimed 93.7%, Janoshik came back 96.2%. 4 points is inter-lab variance, no drama.
comment on switched from 12.5mg to 10mg and the constipation got better, not worse in c/labresults · 19 points · 5 months ago
do not editorialise in the title, put the number in the title and the opinion in the body
comment on help me understand MASH, I have read the wiki twice in c/survodutide · 1 points · 6 months ago
glucagon injection is a different vector than GLP-1
comment on [Lab] 2th independent test on BCH, and the trend is the interesting part in c/labresults · 14 points · 7 months ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on dual agonist — my 21-week log, condensed into one table in c/survodutide · 9 points · 7 months ago
the safety profile is not just tirzepatide amplified
comment on [Vendor] QST order #16 — Denmark, 7 days, no drama, receipts inside in c/tapering · 1 points · 8 months ago
cite the discontinuation data rather than guessing regain rates
comment on Denmark: dual agonist, and what it actually costs here in c/survodutide · 56 points · 9 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on why does nobody talk about biopsy in c/survodutide · 251 points · 1 year ago
glucagon co-agonism has a different safety story